
FRANCE - Idia et al. provide Elitech with EUR 9m
Idia Participations, a subsidiary of Crédit Agricole, has invested EUR 9m in Financere Elitech, a biotech holding company, alongside Naxicap Partners, Banque Populaire Développement, BNP Paribas Développement and Synergie Finance.
The financing round will be used to partially fund the EUR 18.2m purchase of all US-based Nanogen Inc's assets from the Delaware bankruptcy courts for Elitech's designee DxCon. Nanogen is a developer of molecular and rapid diagnostic products. The acquisition adds EUR 25-30m to Financere Elitech's revenues bringing its expected sales in 2010 to EUR 95m. The deal follows Elitech's acquisitions of US-based Wescor and Dutch company Vital Scientific in 2007.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater